PenderFund Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

PenderFund Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-331,110	Closed	-$131K	–	150
2023 Q2	$131K	Buy	+331,110	New	+$99.9K	0.04%	96

PenderFund Capital Management's GRNA Position: Q3 2023 in Review

PenderFund Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 331,110 shares — an estimated $131K sold.

PenderFund Capital Management first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $131K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

PenderFund Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
PenderFund Capital Management sold 331,110 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $131K.
PenderFund Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
PenderFund Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $131K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on PenderFund Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.